[Valve Replacement for Severe Aortic Stenosis in a Patient with Tangier Disease]

Atsushi Tamura1, Takamichi Yoshizaki, Sho Kusadokoro

  • 1Department of Cardiovascular Surgery, Kawaguchi Municipal Medical Center, Kawaguchi, Japan.

Insights

This case study details severe aortic valve stenosis in a Tangier disease patient, a rare occurrence. Surgical aortic valve replacement was successfully performed, highlighting a novel treatment approach for this genetic lipid disorder.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Lipid Metabolism

Background:

  • Tangier disease is a rare genetic disorder characterized by defects in high-density lipoprotein (HDL) metabolism.
  • Patients typically present with low HDL cholesterol and cholesterol ester accumulation in tissues.
  • Aortic valve stenosis is a significant cardiovascular condition, often requiring surgical intervention.

Observation:

  • A 64-year-old female diagnosed with Tangier disease presented with dyspnea.
  • Echocardiography revealed severe aortic valve stenosis with a maximum gradient of 60.5 mmHg.
  • Chest CT demonstrated severe calcification of the ascending aorta and aortic root.

Findings:

  • The patient had pathologically low serum high-density lipoprotein (HDL) levels (4.3 mg/dl) and total cholesterol of 124 mg/dl.
  • Severe aortic valve stenosis was confirmed, necessitating surgical intervention.
  • Aortic valve replacement using a bioprosthetic valve was successfully performed.

Implications:

  • This case highlights the rare association between Tangier disease and severe aortic valve stenosis.
  • Surgical treatment for aortic valve stenosis in Tangier disease patients is exceptionally uncommon.
  • Understanding this link may improve cardiovascular risk assessment and management in Tangier disease patients.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
345
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
499
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
313
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
427
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
906
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
845